Several studies are now focusing on the potential role of purinergic receptors in age-related bone diseases, like osteoporosis, e.g., single-nucleotide polymorphisms (SNPs) of purinergic receptors, that can be found in osteoporosis cohort studies to identify promising candidates for future therapeutic treatment [104,105]. This evidence concerns the gene P2RX1 and osteoporosis.